ALLEGAN, Mich., Sept. 23, 2025 /PRNewswire/ -- Padagis®, a leader in generic pharmaceuticals, today announced a partnership with The Naloxone Project (TNP) to expand access across the U.S. to its life-saving generic naloxone nasal spray. TNP is a clinician-led, nonprofit organization dedicated to dismantling stigma and catalyzing compassionate, patient-centered care for individuals at risk of opioid overdose.

"This partnership represents a unique opportunity for the states we work with," stated Dr. Don Stader, Founder of The Naloxone Project. "By combining Padagis' trusted naloxone spray with our medical expertise, we're able to deliver more than a medication — we're providing enhanced resources, support, and custom solutions to strengthen state programs that save lives."

Through the TNP and Padagis collaboration, states will not only gain access to a lower-cost, high-quality naloxone product, but also the expertise and tailored support that TNP provides. Together, the two organizations are committed to giving states the tools they need to save lives and curb the opioid overdose crisis within their communities.

"At Padagis, we are driven by our mission to improve access to essential medicines that make a difference in people's lives," said Pamela Hoffman, President of Padagis. "Partnering with The Naloxone Project allows us to deliver on that promise by making naloxone more affordable and widely available, while supporting states in enhancing their overdose prevention efforts."

For more information about Padagis, visit www.padagis.com. To learn more about The Naloxone Project, visit www.naloxoneproject.com  

About The Naloxone Project
The Naloxone Project (TNP) is a clinician-founded nonprofit organization dedicated to transforming the response to the opioid crisis. By placing naloxone into the hands of at-risk patients before hospital discharge and championing policies that make this practice sustainable, TNP is not only saving lives today but also reshaping how addiction care is delivered and perceived. Through initiatives such as PACC (Prehospital Addiction Care Consortium) and MOMs (Maternal Overdose Matters), TNP addresses the unique risks faced by perinatal patients as well as the broader population. With fourteen chapters launching across the U.S., the organization is expanding nationwide.

About Padagis
Based in Allegan, Michigan, Padagis is relentlessly committed to reducing healthcare costs and improving accessibility by delivering high-quality medicine through innovative approaches. The pharmaceutical company is a leading provider of extended topical medications and other specialty drugs primarily in the United States. One of Padagis' flagship products is Naloxone, an over-the-counter nasal spray that acts as an antidote for opioid overdoses. Padagis is committed to making its Naloxone nasal spray widely available to help put an end to the opioid crisis and save lives. Padagis employs over 1,300 people worldwide. Visit Padagis online at http://www.padagis.com. 

Media Contact: Abby@thescratchcollective.com, 303.877.0738

View original content to download multimedia:https://www.prnewswire.com/news-releases/padagis-and-the-naloxone-project-partner-to-expand-nationwide-access-to-lifesaving-naloxone-302562573.html

SOURCE Padagis